Real world study for the concordance between IBM Watson for Oncology and clinical practice in advanced non‐small cell lung cancer patients at a lung cancer center in China

Real world study for the concordance between IBM Watson for Oncology and clinical practice in advanced non‐small cell lung cancer patients at a lung cancer center in China

Background IBM Watson for Oncology (WFO) provides physicians with evidence‐based treatment options. This study was designed to explore the concordance of the suggested therapeutic regimen for advanced non‐small cell lung (NSCLC) cancer patients between the updated version of WFO and physicians in ou...

Full description

Bibliographic Details
Main Authors: Shuyang Yao, Ruotian Wang, Kun Qian, Yi Zhang
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Thoracic Cancer
Subjects:
Advanced disease
artificial intelligence
concordance
non‐small cell lung cancer
Watson for Oncology
Online Access:https://doi.org/10.1111/1759-7714.13391

Internet

https://doi.org/10.1111/1759-7714.13391

Similar Items